This article is more than 5 years old. Information may no longer be current.

Cangrelor possibly has new place in clinical practice

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN FRANCISCO — Jessica L. Mega, MD, from Brigham and Women’s Hospital, discuss results from the CHAMPION PHOENIX trial, noting that, with the benefits offered by cangrelor, that it will be interesting to see where this new agent fits into clinical practice.